Novartis Sues Generics Maker Over Organ Rejection Drug
Novartis Pharmaceuticals Corp. hit Roxane Laboratories Inc. with a patent infringement suit in Delaware federal court Tuesday in an effort to block a generic version of Zortress, a medication used to...To view the full article, register now.
Already a subscriber? Click here to view full article